Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 03, 16:00
Infinity Pharmaceuticals Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | 87.10M |
| September 30, 2021 | 88.10M |
| June 30, 2021 | 94.04M |
| March 31, 2021 | 94.00M |
| December 31, 2020 | 27.44M |
| September 30, 2020 | 26.13M |
| June 30, 2020 | 19.69M |
| March 31, 2020 | 19.68M |
| December 31, 2019 | 27.73M |
| September 30, 2019 | 27.72M |
| June 30, 2019 | 27.67M |
| March 31, 2019 | 33.80M |
| December 31, 2018 | 5.619M |
| September 30, 2018 | 5.661M |
| June 30, 2018 | 5.595M |
| March 31, 2018 | -0.601M |
| December 31, 2017 | -0.146M |
| September 30, 2017 | -0.465M |
| June 30, 2017 | -0.488M |
| March 31, 2017 | -0.132M |
| December 31, 2016 | -0.083M |
| September 30, 2016 | 0.622M |
| June 30, 2016 | 0.723M |
| March 31, 2016 | 1.10M |
| December 31, 2015 | 2.321M |
| Date | Value |
|---|---|
| September 30, 2015 | 3.684M |
| June 30, 2015 | 3.571M |
| March 31, 2015 | 2.933M |
| December 31, 2014 | 3.723M |
| September 30, 2014 | 3.018M |
| June 30, 2014 | 4.052M |
| March 31, 2014 | 5.149M |
| December 31, 2013 | 5.673M |
| September 30, 2013 | 179.05M |
| June 30, 2013 | 294.11M |
| March 31, 2013 | 295.46M |
| December 31, 2012 | 293.68M |
| September 30, 2012 | 169.30M |
| June 30, 2012 | 53.63M |
| March 31, 2012 | 51.26M |
| December 31, 2011 | 50.58M |
| September 30, 2011 | 0.5124M |
| June 30, 2011 | 0.3045M |
| March 31, 2011 | 0.2328M |
| December 31, 2010 | 0.235M |
| September 30, 2010 | 0.1838M |
| June 30, 2010 | 0.1078M |
| March 31, 2010 | 0.026M |
| December 31, 2009 | 11.97M |
| September 30, 2009 | 33.71M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
19.68M
Minimum
Mar 2020
94.04M
Maximum
Jun 2021
49.03M
Average
27.72M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
| Athersys Inc | 11.63M |
| Merck & Co Inc | -4.81B |
| MEI Pharma Inc | -11.66M |
| Humanigen Inc | -1.537M |
| Bristol-Myers Squibb Co | 8.278B |